TNFSF10 and scleroderma: Promoting fibroblast death has shown beneficial outcomes in models of fibrosis, for example with the administration of TNF-related apoptosis-inducing ligand (TRAIL) related compounds like TLY012, which reduced fibrosis in a model of scleroderma (117).